News

Element Strengthens Leadership Team to Advance Novel Applications Development and Scientific Affairs

Element Biosciences Closes Acquisition of Loop Genomics

Element Biosciences Bolsters Leadership Team to Advance Development and Commercialization of DNA Sequencing Platform

Element Biosciences Closes $276 Million Series C Financing to Democratize Access to Genomics

Element Biosciences Appoints Chief Commercial Officer, General Counsel, and VP of Operations

Element Raises $30M in Additional Series B Financing to Accelerate Development of a New Sequencing Platform

Element Biosciences Raises $80M in Series B Financing to Accelerate Development of a New DNA Sequencing Platform

Element Biosciences Moves to Alexandria GradLabs in Anticipation of Growth and Expansion
